Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 11, 2022 | Corporate Round | $290M | 1 | Roche | — | Detail |
Dec 7, 2021 | Series D | $300M | 31 | Perceptive Advisors , RA Capital Management | — | Detail |
Aug 26, 2020 | Series C | $270M | 22 | Bain Capital Life Sciences , Perceptive Advisors | — | Detail |
Jul 24, 2019 | Series B | $160M | 16 | Polaris Partners , RA Capital Management | — | Detail |
Aug 28, 2017 | Series A | $7M | 12 | Section 32 | — | Detail |
Mar 1, 2017 | Series A | $65M | 12 | Andreessen Horowitz | — | Detail |
Jun 9, 2016 | Seed | $5.55M | 4 | Andreessen Horowitz | — | Detail |
Dec 1, 2014 | Seed | — | 1 | Loxbridge Research | — | Detail |